IZUMI RAQUEL E. (Chief Operations Officer) purchased 24.0% of their position (16.48K shares) of VINCERX PHARMA, INC. on the open market
Open‑market purchase worth $14.9K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/10/2023ACC: 0000950170-23-041513
DirectorOfficer10% Owner· Chief Operations Officer
Since Dec 2020
+16.48K
Net shares
Net buyer
$14.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
16.48K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+13.04K
Price / share
$0.90
Trade value
$11.74K
% of position
19.0%
8/9/2023
68.74K→81.77K
Common Stock
Indirect
Shares
+3.44K
Price / share
$0.93
Trade value
$3.20K
% of position
4.2%
8/10/2023
81.77K→85.21K
Total
Net shares
+16.48K
Net value
$14.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/9/2023 | P · Purchase | +13.04K | $0.90 | $11.74K | 19.0% | 68.74K | 81.77K |
| Common Stock Indirect | 8/10/2023 | P · Purchase | +3.44K | $0.93 | $3.20K | 4.2% | 81.77K | 85.21K |
| Total | +16.48K | $14.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1K
Common Stock
DirectShares owned1.62M
Total
1.62M direct·1K indirect1.62M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1K | Indirect |
| Common Stock | 1.62M | Direct |
| Total | 1.62M | 1.62M direct·1K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported